• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Comment: Breaking the cycle of neglect: building on momentum from COVID-19 to drive access to diagnostic testing - The Lancet

Mary Wilson

Well-known member
Vol 57 March, 2023

https://doi.org/10. 1016/j.eclinm.2023. 101867

Emma Hannaya and Madhukar Paib,∗

Diagnostic testing is at the heart of quality healthcare. However, due to neglect of diagnostics, nearly half the world’s population lacks access to essential tests.1 The Covid-19 pandemic has shone a harsh spotlight on in- equities in access to testing. Only about 35% of tests administered worldwide have been used in low- and lower-middle- income countries (LMICs), where 75% of the global population lives.2 At the same time, the pandemic set off a boom in diagnostics.3 We have identified ten opportunities (Table) created by the pandemic that could be leveraged to drive better access to testing in general. ...

https://www.thelancet.com/action/showPdf?pii=S2589-5370(23)00044-5
 
Back
Top